Drug profile · INN
doxorubicin hydrochloride (as pegylated liposomal)
CAELYX
doxorubicin hydrochloride (as pegylated liposomal) (CAELYX) is a dna inhibitor. Associated with BAXTER HEALTHCARE PTY LTD.
TGA: approved
Patents linked 0
Pipeline programs 6
News articles 0
Drug details — doxorubicin hydrochloride (as pegylated liposomal)
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 6
- Data quality
- 0.81
Quick answer
doxorubicin hydrochloride (as pegylated liposomal) (CAELYX) is a dna inhibitor. Associated with BAXTER HEALTHCARE PTY LTD.
Key facts
INN doxorubicin hydrochloride (as pegylated liposomal)
Brand CAELYX
Mechanism DNA inhibitor
Target DNA
Originator BAXTER HEALTHCARE PTY LTD
Mechanism of action
DNA inhibitor
Primary target: DNA
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is doxorubicin hydrochloride (as pegylated liposomal)?
doxorubicin hydrochloride (as pegylated liposomal) (CAELYX) is a dna inhibitor. Associated with BAXTER HEALTHCARE PTY LTD.
What is the brand name for doxorubicin hydrochloride (as pegylated liposomal)?
CAELYX is a marketed brand name for doxorubicin hydrochloride (as pegylated liposomal). Check FDA Drugs@FDA for the current US label holder and prescribing information.